AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.13) per share. This is a 62.5 percent decrease over losses of $(0.08) per share from the same period last year.
Elon Musk’s Biography Unveils Why He’s Not A ‘Blockchain Acolyte’ Despite Having Fun With Dogecoin
Elon Musk’s new biography explores various aspects of his life and delves into his involvement with the meme cryptocurrency Dogecoin&nbs